"Anti-Mullerian Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glycoprotein that causes regression of MULLERIAN DUCTS. It is produced by SERTOLI CELLS of the TESTES. In the absence of this hormone, the Mullerian ducts develop into structures of the female reproductive tract. In males, defects of this hormone result in persistent Mullerian duct, a form of MALE PSEUDOHERMAPHRODITISM.
| Descriptor ID |
D054304
|
| MeSH Number(s) |
D06.472.334.984.500
|
| Concept/Terms |
Anti-Mullerian Hormone- Anti-Mullerian Hormone
- Anti Mullerian Hormone
- Antimullerian Hormone
- Mullerian Inhibiting Hormone
- Mullerian Inhibiting Substance
- Mullerian-Inhibitory Substance
- Mullerian Inhibitory Substance
- Mullerian-Inhibiting Factor
- Mullerian Inhibiting Factor
- Mullerian-Inhibiting Hormone
- Anti-Mullerian Factor
- Anti Mullerian Factor
- Mullerian Regression Factor
|
Below are MeSH descriptors whose meaning is more general than "Anti-Mullerian Hormone".
Below are MeSH descriptors whose meaning is more specific than "Anti-Mullerian Hormone".
This graph shows the total number of publications written about "Anti-Mullerian Hormone" by people in this website by year, and whether "Anti-Mullerian Hormone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2013 | 2 | 0 | 2 |
| 2015 | 5 | 1 | 6 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 3 | 0 | 3 |
| 2019 | 2 | 1 | 3 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 2 | 3 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Mullerian Hormone" by people in Profiles.
-
Anti-Mullerian hormone (AMH) protects ovarian follicle loss by downregulating granulosa cell function in in vitro and in vivo models. J Assist Reprod Genet. 2025 Jun; 42(6):2029-2037.
-
Dose-Dense Chemotherapy Regimen for Breast Cancer Associated with Significant Decline in Ovarian Reserve. J Adolesc Young Adult Oncol. 2024 06; 13(3):465-468.
-
Comparison of Female Ovarian Reserve Before vs After COVID-19 Vaccination. JAMA Netw Open. 2023 06 01; 6(6):e2318804.
-
Leuprolide Protects Ovarian Reserve in Adolescents Undergoing Gonadotoxic Therapy. J Adolesc Young Adult Oncol. 2023 12; 12(6):828-834.
-
Markers of ovarian reserve are associated with reproductive age acceleration in granulosa cells from IVF patients. Hum Reprod. 2022 09 30; 37(10):2438-2445.
-
A Case-Control Study of Follicular Fluid Cytokine Profiles in Women with Diminished Ovarian Reserve. Reprod Sci. 2022 09; 29(9):2515-2524.
-
Association of ovarian response with picoAMH in women undergoing controlled ovarian hyperstimulation. Clin Biochem. 2021 Sep; 95:34-40.
-
Anti-M?llerian Hormone (AMH) regulates BRCA1 and BRCA2 gene expression after ovarian cortex transplantation. Gynecol Endocrinol. 2021 Apr; 37(4):349-352.
-
Recombinant Anti-M?llerian Hormone (rAMH) for Stalling In Vitro Granulosa Cell Replication. Reprod Sci. 2020 10; 27(10):1873-1878.
-
Effect of clomiphene citrate treatment on the Sertoli cells of dysmetabolic obese men with low testosterone levels. Clin Endocrinol (Oxf). 2020 01; 92(1):38-45.